Aimax Bhd (XKLS:0041) EBITDA Margin %: 1,065.34% (As of Sep. 2025) — 21122% Above Median


What is Aimax Bhd EBITDA Margin %?

Aimax Bhd XKLS:0041 EBITDA Margin % is 1,065.34% as of Sep. 2025, which is 21122% above its 10-year median of 5.02. The stock has 8 warning signs investors should review. Among 549 Conglomerates companies, Aimax Bhd ranks better than 96.36% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Aimax Bhd's EBITDA for the three months ended in Sep. 2025 was RM28.55 Mil. Aimax Bhd's Revenue for the three months ended in Sep. 2025 was RM2.68 Mil. Therefore, Aimax Bhd's EBITDA margin for the quarter that ended in Sep. 2025 was 1,065.34%.


Aimax Bhd  (XKLS:0041) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Aimax Bhd EBITDA Margin % Related Terms


Aimax Bhd EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Aimax Bhd's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aimax Bhd EBITDA Margin % Chart

Aimax Bhd Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Mar19 Mar20 Sep22 Sep23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.49 -109.21 -155.11 65.63 -226.23

Aimax Bhd Quarterly Data
Mar20 Jun20 Sep20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.78 147.53 -106.06 -491.25 1,065.34

XKLS:0041 vs HON, MMM: EBITDA Margin % Comparison

For the Conglomerates subindustry, Aimax Bhd's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aimax Bhd EBITDA Margin % vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, Aimax Bhd's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Aimax Bhd's EBITDA Margin % falls into.



Aimax Bhd EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Aimax Bhd's EBITDA Margin % for the fiscal year that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-30.985/13.696
=-226.23 %

Aimax Bhd's EBITDA Margin % for the quarter that ended in Sep. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=28.551/2.68
=1,065.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 1,065.34% mean?
Aimax Bhd (XKLS:0041) has a EBITDA Margin % of 1,065.34% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aimax Bhd and its competitors. This is 21122% above median its historical median of 5.02. According to the industry distribution chart, Aimax Bhd ranks #20 out of 549 companies in the Conglomerates industry, placing it in the top 3.6%.
Is Aimax Bhd's EBITDA Margin % too high?
Aimax Bhd's current EBITDA Margin % of 1,065.34% is 21122% above median its 10-year median of 5.02. The Conglomerates industry median EBITDA Margin % is 12.24. Aimax Bhd's value of 1,065.34% is 8603.8% above this industry median. Based on the distribution chart, Aimax Bhd ranks #20 out of 549 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers.
How does Aimax Bhd's EBITDA Margin % compare to HON and MMM?
According to the Conglomerates industry distribution chart, Aimax Bhd ranks #20 out of 549 companies for EBITDA Margin %. This places Aimax Bhd in the top 4% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 12.24. Aimax Bhd's value of 1,065.34% is 8603.8% above this benchmark. While the company's 10-year median is 5.02 vs. the industry median of 12.24, Aimax Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Conglomerates company?
The median EBITDA Margin % among Conglomerates companies is 12.24, based on 549 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aimax Bhd's current EBITDA Margin % of 1,065.34% is 8603.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aimax Bhd and its competitors. For the Conglomerates industry, the median EBITDA Margin % is 12.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aimax Bhd's current EBITDA Margin % is 1,065.34%, which is 21122% above median its own 10-year median of 5.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aimax Bhd stock overvalued right now?
Based on GuruFocus' analysis, Aimax Bhd (XKLS:0041) is currently considered Fairly Valued. The stock's GF Value™ is RM0.01, compared to a current price of RM0.01 — trading right at its estimated fair value. The current EBITDA Margin % is 1,065.34%, which is 21122% above median its 10-year median of 5.02 and 8603.8% above the Conglomerates industry median of 12.24. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Aimax Bhd (XKLS:0041), the current EBITDA Margin % is 1,065.34% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aimax Bhd Business Description

Address C-01-3, Block C Plaza Glomac, No 6, Jalan SS7/19, Kelana Jaya, Petaling Jaya, SGR, MYS, 47301
Aimax Bhd, formerly known as Hong Seng Consolidated Bhd, is operating as an investment holding company. The company operates in four operating segments. The healthcare segment consists of a medical diagnostic and research laboratory and wholesale of pharmaceutical and medical goods; the Financial services include Moneylending; the Gloves segment consists of Manufacturing and trading of rubber gloves; and Seafood segment which consists of Trading of Seafood products. The majority of the revenue is derived from the healthcare segment.